Lower vs higher ketamine doses to reduce the oculocardiac reflex in eye surgery
Official title: Evaluation of Two Intravenous Doses of Ketamine in Reducing the Oculocardiac Reflex in Adult Patients Undergoing Ophthalmic Surgery: A Randomized Controlled Double-Blinded Trial
Run by Cairo University · NCT07708740 · Data updated 2026-11-12
A single-dose comparison tests whether 0.5 mg/kg IV ketamine works as well as 0.75 mg/kg IV for lowering the oculocardiac reflex in adults having eye surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | July 1, 2026 |
| Main results expected | December 30, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | July 16, 2026 |
| Trial ID | NCT07708740 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 years old scheduled for elective ophthalmic surgery requiring extraocular muscle traction under general anesthesia, with ASA I–II.
✕Probably not a fit
Patients with contraindications to ketamine, preexisting cardiac conduction issues, glaucoma or high intraocular pressure, or ASA > II may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares two intravenous doses of ketamine (0.5 mg/kg vs 0.75 mg/kg) given during elective ophthalmic surgery under general anesthesia to see which dose better reduces the oculocardiac reflex. The OCR can cause bradycardia or other heart changes during eye muscle traction or eye pressure. The trial focuses on adult patients aged 18–65 with ASA I–II, and excludes those with ketamine contraindications or certain eye or heart conditions. Outcomes include OCR incidence and potential side effects related to ketamine emergence and psychomimetic effects.
Why it matters
Potential benefit: If the lower dose is as effective, patients may experience fewer side effects while maintaining protection against OCR.
How similar studies have gone: Prior work has explored ketamine dosing for OCR, but evidence in adults remains limited and this study aims to clarify optimal dosing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 18 to 65 years old. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I, II. * Scheduled for elective ophthalmic surgery involving extraocular muscle traction under general anesthesia. Exclusion Criteria: * Ketamine contraindications (e.g., hypersensitivity, uncontrolled hypertension) * History of cardiac arrhythmia or conduction disorder * Glaucoma or raised intraocular pressure * ASA status greater than II * Patient refusal.
Where it's running
-
Cairo University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Hebatullah S Abdelhamid, MD
- Email: drhebasalah593@gmail.com
- Phone: 00201044512277
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Propofol-Ketamine vs Sevoflurane for anesthesia in kids undergoing heart catheterization
In children needing a heart catheterization, doctors compare using propofol-ketamine versus sevoflurane to see which anesthesia approach is safer and helps kids wake up smoothly.
-
Biomarker-guided antidepressant choice to see if rTMS or ketamine works best for you
This study tests whether brain and behavior markers can help match people with major depression to either rTMS or ketamine to see which works better for them.
-
Anrikefon versus nalbuphine for pain control after eye surgery
This trial will test whether Anrikefon provides pain relief as well as nalbuphine for adults having eye surgery under general anesthesia.
-
Anesthesia methods, neuroprotection, and surgical field in FESS with controlled hypotension
This trial tests whether four different anesthesia maintenance techniques — propofol-remifentanil, propofol-remifentanil with ketamine and magnesium, sevoflurane-remifentanil, and sevoflurane-remifentanil with ketamine and magnesium — better protect the brain and improve the surgical field in adults having FESS under c
-
Esketamine or Crisis Planning Added to Usual Care for Suicidality in Brazil
This trial tests whether a single esketamine infusion or a single Crisis Response Planning session, added to enhanced treatment as usual, can reduce future suicide-related events in adolescents and adults in Indaiatuba, Brazil.
-
Combining Ketamine and Magnesium for Pain Relief After Nose Surgery
This study is testing whether combining ketamine and magnesium during nose surgery can help reduce pain and lower the need for opioids afterward.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.